COPAN Diagnostics announced FDA clearance of its Colibri automated processor, which is used in conjunction with mass spectrometry systems for automating rapid identification of isolated colonies grown on solid culture media.
The COPAN Colibri System is an in vitro diagnostic device for use in conjunction with the bioMérieux VITEK MS or Bruker MALDI Biotyper CA mass spectrometry systems for automating rapid identification of isolated colonies of Gram-negative and Gram-positive bacteria.
Colibri is an automated processor that is a complementary part of WASPLab, COPAN’s full laboratory automation system.
“Clinical Microbiology is facing tremendous challenges including labor shortages, dramatically increased workloads, pressure for on-demand testing and rapid turnaround times for results. The FDA clearance of COPAN’s Colibri will provide time and labor savings by automating a crucial step in diagnostic Microbiology. When used with COPAN’s advanced AI software, the laboratory has total traceability and precision when it comes to colony selection and transfer to MALDI-TOF target slides. A complex task that occurs in Microbiology laboratories tens or hundreds of thousands of times per day which requires great care and attention is now automated with unquestionable accuracy. With this critical process in laboratory workup automated and interfaced with downstream mass spectrometry instruments, experienced laboratory professionals may now use their scarce time to perform other complex tasks requiring their unique skill and expertise,” says COPAN Diagnostics CEO Norman Sharples.
The Colibri system, paired with COPAN’s artificial intelligence (AI) software, PhenoMATRIX, offers clinical Microbiology laboratories intelligence driven solutions for specimen workup to help streamline workflow and address the most challenging demands in the laboratory.
Featured image: Colibri Automated Specimen Workup Instrument by COPAN Receives FDA 510(k) Clearance for Use with MALDI-TOF Mass Spectrometry Analyzers. Photo: COPAN Diagnostics